電気刺激装置の世界市場-2022-2029

市場力学

脊髄損傷に対する電気刺激の革新が市場成長の原動力になると予想されます。

機能的電気刺激（FES）はNMESの一種で、麻痺した神経細胞や筋肉に電気刺激を与え、筋活動を刺激して機能的なタスクを遂行させるものです。FESは、脊髄損傷（SCI）後のリハビリテーションにおいて、主に四肢の機能を回復させるために広く使用されています。FESは筋力生産と抵抗力を向上させる。FESは脊髄損傷後の上肢の機能回復を助ける。また、FESは下肢のリハビリテーションにも活用され、足を引く加速度、振りの力、地面への衝撃力などの歩行特性を高め、より速い歩行速度と歩行のためのより効率的な筋力体系を実現しています。そのため、現在のヘルスケア提供における開発は、外来ベースでFESを提供する戦略に関する研究を刺激しています。

一つの解決策は、Myant社の衣服による刺激技術です（カナダ、トロント）。この衣服は、布と銀糸または導電層を組み合わせ、衣服に電極を埋め込んで電気刺激を与えます。他の解決策と比較して、これらの着用可能な衣服は、調節可能で、費用対効果が高く、多機能で、耐久性があり、患者による独立した適用が可能であることが望ましいです。したがって、上記の記述から、予測期間において市場が牽引されることが期待されます。

理学療法に伴う高コストと厳しいデバイスライセンシングが市場成長の妨げとなります。

理学療法には高いコストがかかるため、デバイスの受容性が限定的です。長い承認プロセスが、新しいアイテムの市場導入の遅れの原因となっています。厳しいデバイスライセンス規制と電気刺激システム代替品の幅広い選択肢が、予測期間中に市場が阻害されると予想される要因です。

COVID-19の影響分析

COVID-19の大流行は、人類が前世紀に直面した最も破壊的な健康危機です。実行可能な医薬品のオプションがないため、この病気との戦いが妨げられています。確かな調査結果に基づいて、電気刺激は現在利用されている対症療法と抗ウイルス剤に対する実行可能な補助剤となり得る。前臨床試験において、電気刺激は呼吸機能の改善、SARS-CoV-2の増殖抑制、疼痛の緩和、免疫力の向上、抗ウイルス薬の浸透性の改善に効果があるとされています。さらに、NMESは筋力強化のためのシンプルで非侵襲的な治療法であり、一般的に忍容性が高く、副作用がなく、患者の介助を必要としないかほとんど必要とせず、比較的安価であることが特徴です。その結果、COVID-19患者の身体および筋肉機能に対するNMES療法の有効性が実証されれば、集中治療後症候群の患者のためのICU後のリハビリテーション・プロトコルに体系的に組み込むことができるようになる可能性があります。

世界の電気刺激装置市場レポートでは、約45以上の市場データ表、40以上の図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

• 市場インパクトファクター
  • 促進要因
    • 麻痺患者向け神経刺激装置の革新が市場成長を牽引すると予想されます。
  • 抑制要因
    • 厳しいデバイスライセンシング規制が市場成長の妨げになると予想されます。
  • 機会
  • 影響分析

第5章 産業分析

• ポーターの5つの力
• アンメットニーズ
• サプライチェーン
• プライシング分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み
• まとめ

第7章 デバイスタイプ別

• 脊髄刺激装置
• 脳深部刺激装置
• 迷走神経刺激装置
• 仙骨神経刺激装置
• 胃電気刺激装置
• 経皮的電気神経刺激装置
• 神経筋電気刺激装置
• 頭蓋内電気刺激装置
• その他

第8章 アプリケーション別

• 疼痛管理
• 神経系・運動器系疾患治療
• 筋骨格系疾患管理
• 代謝・消化器系管理
• 失禁管理
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 脳神経外科センター
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A（合併・買収）分析

第12章 企業プロファイル

• Boston Scientific Corporation
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Cyberonics, Inc
• Colfax Corporation（DJO Global, Inc.）
• Medtronic plc
• Nevro Corporation
• Abbott
• NeuroMetrix, Inc.
• BTL Industries, Inc.
• Cogentix Medical Inc.
• Zynex Inc.

第13章 電気刺激装置の世界市場-DataM

Market Overview

Electric Stimulation Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.42% during the forecast period (2022-2029).

Electrical stimulators are small electronic devices that patients wear and attach to their skin via electrodes. Electrical stimulators are used for a variety of purposes, including the reduction of acute post-operative pain and swelling, the treatment of chronic intractable pain, the maintenance of muscle tone during temporary extremity immobilization, the reduction of spasticity, and the assistance of spinal cord injured patients to grasp, stand, and walk independently. e stimulation device's lead wires and electrodes are attached to the skin over the target area of the body. Electrical stimulators are also utilized at home by patients.

Market Dynamics

Innovations in electrical stimulation for spinal cord injuries are expected to drive market growtth.

Functional electrical stimulation (FES) is a form of NMES that involves administering electrical stimuli to paralyzed neurons or muscles to stimulate muscular activity to fulfill a functional task. FES is used extensively in rehabilitation following a spinal cord injury (SCI), mostly to regain extremities function. FES has boosted muscle power production and resistance. FES aids in the recovery of upper extremity function following SCI. FES has also been utilized in lower extremity rehabilitation to increase gait characteristics such as foot-pulling acceleration, swing power, and ground impact force, resulting in faster walking speeds and a more efficient system of muscle strength for gait. Therefore, current developments in healthcare delivery have stimulated research into strategies to deliver FES on an outpatient basis.

One solution is Myant's garment-based stimulation technology (Toronto, Canada). These garments combine cloth with silver thread or conductive layers to implant electrodes into the clothing to deliver electrical stimulation. Compared to other solutions, these wearable garments should be adjustable, cost-effective, multifunctional, and durable and allow for independent application by the patient. Thus, from the above statements, the market is expected to drive in the forecast period.

High costs and stringent device licensingare associated with physiotherapy treatments will hamper the market growth

High costs are associated with physiotherapy treatments, resulting in limited device acceptability. Long approval processes are causing delays in introducing new items to the market. Stringent device licensing regulations and a wide choice of electrical stimulation system alternatives are the factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is the most devastating health crisis that humanity has faced in the last century. The lack of viable medicinal options has hampered the fight against the disease. Based on solid research findings, electric stimulation can be a viable adjuvant to currently utilized symptomatic therapy and antiviral medications. Based on preclinical studies, electric stimulation can improve respiratory functions, limit SARS-CoV-2 growth, alleviate pain, raise immunity, and improve antiviral medication penetration. Furthermore, NMES is a simple and non-invasive therapy for muscle strengthening that is generally well tolerated, produces no adverse effects, requires no or little assistance from patients, and is relatively inexpensive. As a result, demonstrating the efficacy of NMES therapy for physical and muscle function in COVID-19 patients may support its systematic inclusion in post-ICU rehabilitation protocols for patients with post-intensive care syndrome.

Segment Analysis

Pain Management segment is expected to hold the largest market share in electric stimulation devices market.

The pain management segment accounted for the largest market share in 2021. The segment benefits from the increasing prevalence of chronic pain disorders, and the growing usage of Pain Management products due to their high therapeutic advantages are the factors the market is driven in the forecast period. For instance, chronic pain is estimated to affect 11% to 40% of persons in the United States. The most prevalent chronic pain issue is low back pain. Women and people over the age of 65 are more prone to experience chronic pain. Chronic pain costs the United States up to $635 billion every year. Severe depression affects more than 8 out of 10 chronic pain patients. One in every four patients suffering from chronic pain has a sleep disturbance. Chronic pain affects at least 10% of the world's population. Therefore, the demand for electric stimulation devices for chronic pain has increased. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global electric stimulation devices market

North America accounted for the largest market share in 2021. The rise in chronic pain, the prevalence of sports injuries, the rise in the geriatric population, and significant market competitors focused on obtaining FDA approval for novel products to treat patients are the factors the market is driven in the forecast period. For instance, in May 20, 2022, NeuroMetrix, Inc. announced that its wearable technology for chronic pain therapy had gained 510(k) approval (K140333) from the United States Food and Drug Administration (FDA) for over-the-counter usage. The company is nearing the end of developing a consumer-oriented chronic pain management product. The gadget is built on wearable technology, currently used in the Company's SENSUS Pain Management System, to induce safe and effective pain treatment by gentle, non-invasive electrical stimulation of sensory neurons. It is lightweight and can be worn throughout the day and while sleeping. Thus, for the statements, North America accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the electric stimulation devices market are Boston Scientific Corporation, Cyberonics, Inc, Colfax Corporation (DJO Global, Inc.), Medtronic plc, Nevro Corporation, Abbott, NeuroMetrix, Inc., BTL Industries, Inc., Cogentix Medical Inc., Zynex Inc.

Boston Scientific Corporation:

Overview:

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices used in various interventional medical specialties. The company offers its products in businesses such as Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. Moreover, it operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy, Urology, and Pelvic Health businesses. The rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Across 100+ countries, the company delivers care more effectively by reducing costs, increasing efficiencies, and expanding access to care to help more people live healthier lives.

Product Portfolio:

Precision Novi Primary Cell Spinal Cord Stimulator System: Precision Novi is the smallest, thinnest high, capacity primary cell spinal cord stimulator implant with a unique contoured shape. This improved implant shape was designed to enhance patient comfort and address the primary cause of revision surgeries: pain over the implant site.

The global electric stimulation devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Innovations in the nerve-stimulation device for paralyzed patients are expected to drive market growth.
  • 4.1.2. Restraints:
    • 4.1.2.1. Stringent device licensing regulations are expected to hamper market growth.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces
• 5.2. Unmet Needs
• 5.3. Supply Chain
• 5.4. Pricing Analysis
• 5.5. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Device Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  • 7.1.2. Market Attractiveness Index, By Device Type
• 7.2. Spinal Cord Stimulation Devices*
  • 7.2.1.1. Introduction
  • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Deep Brain Stimulation Devices
• 7.4. Vagus Nerve Stimulation Devices
• 7.5. Sacral Nerve Stimulation Devices
• 7.6. Gastric Electric Stimulation Devices
• 7.7. Transcutaneous Electrical Nerve Stimulation Devices
• 7.8. Neuromuscular Electrical Stimulation Devices
• 7.9. Cranial Electrical Stimulation Devices
• 7.10. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Pain Management*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Neurological and Movement Disorder Management
• 8.4. Musculoskeletal Disorder Management
• 8.5. Metabolism & GIT Management
• 8.6. Incontinence Management
• 8.7. Others

9. By End user

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 9.1.2. Market Attractiveness Index, By End user
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Specialty Clinics
• 9.4. Neurosurgical Centers
• 9.5. Ambulatory Surgical Centers
• 9.6. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Boston Scientific Corporation*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Cyberonics, Inc
• 12.3. Colfax Corporation (DJO Global, Inc.)
• 12.4. Medtronic plc
• 12.5. Nevro Corporation
• 12.6. Abbott
• 12.7. NeuroMetrix, Inc.
• 12.8. BTL Industries, Inc.
• 12.9. Cogentix Medical Inc.
• 12.10. Zynex Inc.

LIST NOT EXHAUSTIVE

13. Global Electric Stimulation Devices Market - DataM

• 13.1. Appendix
• 13.2. About Us and Applications
• 13.3. Contact Us